In vivo limiting dilution tumor formation assays have demonstrated that CD133-positive tumor cells are highly tumorigenic in brains of immunocompromised mice, whereas CD133-negative cells seldom form detectable tumors (7, 61). The gene discussed is PROM1; the disease is neoplasm.